Lexston Life Sciences Corp.'s total assets for Q4 2025 were C$279.49K, a decrease of -57.33% from the previous quarter. TSE:LEXT total liabilities were C$208.82K for the fiscal quarter, a 46.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.